— Know what they know.
Not Investment Advice

AVIR NASDAQ

Atea Pharmaceuticals, Inc.
1W: -0.7% 1M: -24.4% 3M: -8.8% YTD: +21.8% 1Y: +46.2% 3Y: +22.5% 5Y: -81.5%
$4.42
+0.18 (+4.25%)
 
Weekly Expected Move ±9.8%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $353.7M mcap · 60M float · 0.741% daily turnover · Short 55% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
30.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 587.0%
Cost Advantage
33
Intangibles
25
Switching Cost
30
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AVIR has No discernible competitive edge (30.9/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 587.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$10
Avg Target
$10
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 2Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$10.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-09 Evercore ISI Initiated $10 +62.6% $6.15
2024-08-12 Morgan Stanley Matthew Harrison Initiated $7 +105.4% $3.35

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
4
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AVIR receives an overall rating of C+. Strongest factors: D/E (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-12 B- C+
2026-05-06 C+ B-
2026-04-01 B- C+
2026-03-09 C B-
2026-03-06 B- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
85
Earnings Quality
59
Growth
Value
32
Momentum
Safety
80
Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.19
Safe Zone
Piotroski F-Score
2/9
Beneish M-Score
Ohlson O-Score
-1.33
Bankruptcy prob: 20.9%
Moderate
Credit Rating
A-
Score: 69.6/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.87x
Accruals: -5.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AVIR scores 3.19, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AVIR scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AVIR's implied 20.9% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AVIR receives an estimated rating of A- (score: 69.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.07x
PEG
0.09x
P/S
0.00x
P/B
1.50x
P/FCF
-2.88x
P/OCF
EV/EBITDA
-0.67x
EV/Revenue
EV/EBIT
-0.67x
EV/FCF
-0.85x
Earnings Yield
-39.78%
FCF Yield
-34.70%
Shareholder Yield
5.99%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AVIR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.964
NI / EBT
×
Interest Burden
0.944
EBT / EBIT
×
EBIT Margin
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.092
Assets / Equity
=
ROE
-47.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AVIR's ROE of -47.5% is driven by A tax burden ratio of 0.96 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1396 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.42
Median 1Y
$2.32
5th Pctile
$0.61
95th Pctile
$8.84
Ann. Volatility
77.4%
Analyst Target
$10.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jean-Pierre Sommadossi, PhD
President, Chief Executive Officer and Chairman of the Board
$703,490 $1,315,800 $3,403,752
Janet Hammond, MD,
PhD Chief Development Officer
$590,892 $459,000 $1,767,234
Andrea Corcoran Financial
ancial Officer, Executive Vice President, Legal
$549,530 $442,170 $1,690,428
Maria Arantxa Horga,
MD Chief Medical Officer
$523,644 $425,034 $1,593,827
John Vavricka Commercial
ercial Officer
$443,169 $292,842 $1,217,738

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,403,752
Avg Employee Cost (SGA/emp): $597,509
Employees: 55

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
55
-1.8% YoY
Revenue / Employee
Profit / Employee
$-2,879,073
NI: $-158,349,000
SGA / Employee
$597,509
Avg labor cost proxy
R&D / Employee
$2,691,345
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 9.7% 4.5% 19.3% 7.7% 2.5% 5.7% -17.2% -16.2% -15.7% -19.4% -22.7% -27.4% -29.4% -29.1% -33.9% -28.1% -27.4% -29.6% -44.3% -47.5% -47.46%
ROA 6.1% 2.9% 14.8% 5.9% 1.9% 4.4% -16.1% -15.2% -14.7% -18.2% -21.6% -25.9% -27.9% -27.6% -31.8% -26.3% -25.7% -27.8% -40.6% -43.5% -43.47%
ROIC -17.5% -8.1% -2.2% -89.1% -27.3% -55.6% 34.3% 34.1% 34.9% 41.3% 6.3% 7.4% 7.9% 7.7% 10.7% 9.0% 8.7% 9.2% 5.6% 5.9% 5.87%
ROCE 11.0% 6.9% 19.3% 9.2% 3.4% 4.2% -18.2% -18.1% -17.6% -19.8% -24.9% -30.0% -33.1% -33.2% -40.6% -33.7% -32.4% -34.9% -64.4% -67.6% -67.61%
Gross Margin 34.1% -31.1% 69.9%
Operating Margin 14.4% -67.5% 63.1%
Net Margin 2.5% -85.9% 60.9%
EBITDA Margin 14.4% -67.5% 63.1%
FCF Margin 1.6% 1.5% -24.8% -45.3% -59.1% -92.0%
OCF Margin 1.6% 1.5% -24.8% -45.3% -58.2% -91.0%
ROE 3Y Avg snapshot only -40.94%
ROE 5Y Avg snapshot only -26.61%
ROA 3Y Avg snapshot only -37.10%
ROIC Economic snapshot only -54.29%
Cash ROA snapshot only -46.91%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 35.76 117.48 6.42 12.41 38.07 13.29 -3.46 -2.55 -2.94 -1.91 -1.87 -2.07 -1.58 -1.63 -1.68 -1.83 -2.21 -1.56 -1.76 -2.51 -2.065
P/S Ratio 10.81 13.97 2.22 2.10 2.63 2.47 0.000
P/B Ratio 3.45 5.30 1.10 0.85 0.83 0.67 0.63 0.44 0.49 0.39 0.46 0.61 0.50 0.51 0.64 0.58 0.69 0.52 1.01 1.55 1.498
P/FCF 6.65 9.46 -8.95 -4.65 -4.45 -2.68 -3.26 -2.98 -3.51 -2.94 -2.98 -3.55 -2.30 -2.23 -2.09 -2.02 -2.58 -1.71 -2.11 -2.88 -2.882
P/OCF 6.65 9.46
EV/EBITDA 17.37 54.22 0.10 -2.50 -7.03 -9.49 2.07 3.12 2.91 3.07 2.30 1.41 1.60 1.57 0.94 1.32 1.05 1.44 0.12 -0.67 -0.673
EV/Revenue 5.95 9.88 0.04 -0.57 -0.77 -1.51
EV/EBIT 17.37 54.26 0.10 -2.50 -7.04 -9.54 2.06 3.11 2.90 3.06 2.29 1.40 1.59 1.57 0.94 1.32 1.05 1.44 0.12 -0.67 -0.672
EV/FCF 3.67 6.69 -0.17 1.27 1.30 1.64 1.98 3.89 3.74 4.62 3.76 2.48 2.44 2.31 1.26 1.57 1.30 1.67 0.17 -0.85 -0.846
Earnings Yield 2.8% 0.9% 15.6% 8.1% 2.6% 7.5% -28.9% -39.2% -34.0% -52.4% -53.4% -48.3% -63.1% -61.5% -59.5% -54.8% -45.2% -64.1% -56.8% -39.8% -39.78%
FCF Yield 15.0% 10.6% -11.2% -21.5% -22.5% -37.3% -30.7% -33.6% -28.5% -34.0% -33.6% -28.1% -43.6% -44.9% -47.9% -49.6% -38.8% -58.5% -47.3% -34.7% -34.70%
PEG Ratio snapshot only 0.086
Price/Tangible Book snapshot only 1.547
Shareholder Yield snapshot only 5.99%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.73 2.73 13.58 13.58 13.58 13.58 35.77 35.77 35.77 35.77 18.24 18.24 18.24 18.24 24.85 24.85 24.85 24.85 7.82 7.82 7.817
Quick Ratio 2.73 2.73 13.58 13.58 13.58 13.58 35.77 35.77 35.77 35.77 18.24 18.24 18.24 18.24 24.85 24.85 24.85 24.85 7.82 7.82 7.817
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.003
Net Debt/Equity -1.55 -1.55 -1.08 -1.08 -1.08 -1.08 -1.00 -1.00 -1.00 -1.00 -1.04 -1.04 -1.04 -1.04 -1.03 -1.03 -1.03 -1.03 -1.09 -1.09 -1.093
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.003
Debt/EBITDA 0.00 0.00 0.00 0.00 0.01 0.01 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00 -0.005
Net Debt/EBITDA -14.17 -22.45 -5.52 -11.65 -31.03 -24.98 5.47 5.51 5.65 5.02 4.11 3.42 3.10 3.09 2.51 3.02 3.14 2.92 1.70 1.62 1.620
Interest Coverage
Equity Multiplier 1.58 1.58 1.09 1.09 1.09 1.09 1.04 1.04 1.04 1.04 1.07 1.07 1.07 1.07 1.06 1.06 1.06 1.06 1.14 1.14 1.144
Cash Ratio snapshot only 7.587
Cash to Debt snapshot only 358.043
FCF to Debt snapshot only -175.396
Defensive Interval snapshot only 588.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.20 0.24 0.43 0.35 0.27 0.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover
Receivables Turnover 30.10 35.74 120.85 98.15 77.38 66.10
Payables Turnover 1337.00 2053.98 72.79 74.13 56.80 38.07 12.52 12.33 16.88 21.98 18.60 10.11 5.40 5.95 4.65 5.41 5.94 1.37 0.67 0.29 0.290
DSO 12 10 3 4 5 6
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 0 0 5 5 6 10 29 30 22 17 20 36 68 61 79 67 61 267 542 1259 1258.8 days
Cash Conversion Cycle 12 10 -2 -1 -2 -4
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 6.2% 1.5% 28.6% -7.5% -1.0% -1.0% -1.0% -1.0%
Net Income 4.9% -5.8% -70.7% 44.3% -2.0% -3.3% -7.8% -4.7% -17.3% -49.7% -65.8% -32.6% -23.9% 14.8% 22.7% 15.5% 6.0% -21.5% -21.53%
EPS 5.0% 0.9% -69.0% 43.5% -2.0% -3.3% -7.8% -4.7% -17.1% -48.7% -64.1% -31.0% -22.3% 16.0% 22.2% 9.8% -1.7% -30.7% -30.68%
FCF -1.3% -1.4% -1.5% -1.6% -41.3% 27.5% 33.2% 51.9% 30.5% -1.8% -36.9% -49.2% -58.7% -32.3% 3.8% -5.7% 2.6% -17.2% -17.17%
EBITDA 5.7% 27.8% -59.0% -19.2% -1.8% -2.8% -5.6% -5.2% -19.0% -43.9% -63.2% -45.2% -29.0% 10.9% 22.3% 16.6% 2.1% -24.0% -24.01%
Op. Income 5.7% 27.8% -59.1% -19.6% -1.9% -3.0% -6.4% -6.2% -25.7% -47.9% -53.5% -27.3% -17.5% 15.7% 23.3% 17.7% 6.3% -17.1% -17.06%
OCF Growth snapshot only -17.17%
Asset Growth snapshot only -32.16%
Equity Growth snapshot only -37.24%
Debt Growth snapshot only -48.66%
Shares Change snapshot only -7.00%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -11.7% -11.7% -11.7% -11.7% -15.6% -15.6% -15.6% -15.6% -22.1% -22.1% -22.10%
Assets 5Y -18.3% -18.3% -18.26%
Equity 3Y 0.4% 0.4% 0.4% 0.4% -14.8% -14.8% -14.8% -14.8% -24.5% -24.5% -24.52%
Book Value 3Y 2.7% 2.5% 2.0% -0.2% -13.9% -15.5% -15.0% -13.3% -22.9% -23.2% -23.23%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.02 0.16 0.55 0.81 0.14 0.36 0.68 0.83 0.60 0.60 0.60 0.60 0.66 0.66 0.662
Earnings Stability 0.33 0.76 0.91 0.70 0.57 0.89 0.96 0.85 0.67 0.81 0.82 0.76 0.66 0.80 0.797
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.90 0.94 0.91 0.94 0.98 0.91 0.914
Earnings Smoothness 0.00 0.94 0.00 0.64
ROE Trend -0.29 -0.25 -0.22 -0.25 -0.24 -0.24 -0.25 -0.24 -0.17 -0.09 -0.07 -0.08 -0.26 -0.31 -0.309
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate 9.7% 4.5% 19.3% 7.7% 2.5% 5.7%
Internal Growth Rate 6.5% 2.9% 17.4% 6.3% 1.9% 4.6%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 5.37 12.42 -0.72 -2.67 -8.44 -4.90 1.04 0.84 0.84 0.65 0.63 0.58 0.69 0.73 0.80 0.90 0.86 0.91 0.83 0.87 0.872
FCF/OCF 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.872
CapEx/Revenue 0.0% 0.0% 0.0% 0.0% 0.9% 1.0%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.27 -0.33 0.25 0.22 0.18 0.26 0.01 -0.02 -0.02 -0.06 -0.08 -0.11 -0.09 -0.07 -0.06 -0.03 -0.04 -0.02 -0.07 -0.06 -0.056
Sloan Accruals snapshot only -0.444
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.7% 11.1% 9.1% 6.0% 5.99%
Net Buyback Yield -0.0% -0.0% -0.2% -0.2% -0.2% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% 4.6% 11.1% 8.9% 5.7% 5.65%
Total Shareholder Return -0.0% -0.0% -0.2% -0.2% -0.2% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% 4.6% 11.1% 8.9% 5.7% 5.65%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.88 0.65 0.87 0.74 0.60 0.99 0.97 0.97 0.97 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 0.96 0.96 0.964
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.05 1.18 1.01 0.96 0.96 1.01 0.96 0.96 0.94 0.93 0.93 0.92 0.93 0.94 0.93 0.94 0.944
EBIT Margin 0.34 0.18 0.39 0.23 0.11 0.16
Asset Turnover 0.20 0.24 0.43 0.35 0.27 0.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.58 1.58 1.30 1.30 1.30 1.30 1.07 1.07 1.07 1.07 1.06 1.06 1.06 1.06 1.07 1.07 1.07 1.07 1.09 1.09 1.092
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.60 $0.30 $1.39 $0.58 $0.19 $0.43 $-1.39 $-1.31 $-1.27 $-1.57 $-1.63 $-1.95 $-2.09 $-2.06 $-1.99 $-1.64 $-1.63 $-1.86 $-2.03 $-2.14 $-2.14
Book Value/Share $6.22 $6.61 $8.15 $8.54 $8.53 $8.53 $7.69 $7.69 $7.68 $7.68 $6.65 $6.62 $6.59 $6.58 $5.20 $5.15 $5.24 $5.55 $3.53 $3.48 $2.95
Tangible Book/Share $6.22 $6.61 $8.15 $8.54 $8.53 $8.53 $7.69 $7.69 $7.68 $7.68 $6.65 $6.62 $6.59 $6.58 $5.20 $5.15 $5.24 $5.55 $3.53 $3.48 $3.48
Revenue/Share $1.99 $2.51 $4.03 $3.43 $2.70 $2.31 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $3.23 $3.71 $-1.00 $-1.55 $-1.60 $-2.12 $-1.48 $-1.12 $-1.06 $-1.02 $-1.02 $-1.14 $-1.44 $-1.50 $-1.60 $-1.48 $-1.40 $-1.70 $-1.69 $-1.87 $-1.87
OCF/Share $3.23 $3.71 $-1.00 $-1.55 $-1.57 $-2.10 $-1.45 $-1.10 $-1.06 $-1.02 $-1.02 $-1.14 $-1.44 $-1.50 $-1.60 $-1.48 $-1.40 $-1.70 $-1.69 $-1.87 $-1.87
Cash/Share $9.65 $10.27 $8.78 $9.19 $9.18 $9.18 $7.76 $7.76 $7.75 $7.75 $6.93 $6.89 $6.86 $6.85 $5.38 $5.34 $5.43 $5.75 $3.86 $3.81 $3.23
EBITDA/Share $0.68 $0.46 $1.59 $0.79 $0.30 $0.37 $-1.41 $-1.40 $-1.36 $-1.54 $-1.68 $-2.00 $-2.21 $-2.20 $-2.14 $-1.76 $-1.72 $-1.96 $-2.26 $-2.35 $-2.35
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.04 $0.04 $0.04 $0.04 $0.03 $0.03 $0.03 $0.03 $0.02 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01
Net Debt/Share $-9.65 $-10.27 $-8.77 $-9.19 $-9.18 $-9.18 $-7.73 $-7.72 $-7.72 $-7.72 $-6.90 $-6.86 $-6.83 $-6.82 $-5.36 $-5.32 $-5.41 $-5.73 $-3.85 $-3.80 $-3.80
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.188
Altman Z-Prime snapshot only 7.515
Piotroski F-Score 4 4 5 4 4 3 2 2 2 2 1 1 1 1 2 3 4 4 2 2 2
Beneish M-Score 1.48
Ohlson O-Score snapshot only -1.333
ROIC (Greenblatt) snapshot only -68.39%
Net-Net WC snapshot only $3.42
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A-
Credit Score 89.00 89.00 86.84 86.84 87.34 87.48 76.78 76.20 76.41 76.48 74.20 76.44 74.06 73.63 76.29 76.25 76.42 76.04 49.07 69.62 69.624
Credit Grade snapshot only 7
Credit Trend snapshot only -6.625
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 70
Sector Credit Rank snapshot only 64

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms